Neutral
Is CRISPR Therapeutics’ (CRSP) ESOP Shelf Registration Quietly Redefining Its Long‑Term Risk‑Reward Profile?
CRISPR Therapeutics (CRSP) recently filed a US$969.16 million ESOP-related shelf registration and amended its articles of association, prompting inves...